Identification of different subtypes of breast cancer using tissue microarray

被引:0
作者
Munirah, M. A. [1 ]
Siti-Aishah, M. A. [1 ]
Reena, M. Z. [1 ]
Sharifah, N. A. [1 ]
Rohaizak, M. [2 ]
Norlia, A. [2 ]
Rafie, M. K. M. [3 ]
Asmiati, A. [3 ]
Hisham, A. [4 ]
Fuad, I. [5 ]
Shahrun, N. S. [2 ]
Das, S. [6 ]
机构
[1] Univ Kebangsaan Malaysia, Fac Med, Dept Pathol, Med Ctr, Kuala Lumpur 56000, Malaysia
[2] Univ Kebangsaan Malaysia, Fac Med, Dept Surg, Med Ctr, Kuala Lumpur 56000, Malaysia
[3] Hosp Putrajaya, Dept Pathol, Selangor, Malaysia
[4] Hosp Putrajaya, Dept Surg, Selangor, Malaysia
[5] Univ Kebangsaan Malaysia, Med Ctr, Dept Radiotherapy & Oncol, Kuala Lumpur 56000, Malaysia
[6] Univ Kebangsaan Malaysia, Fac Med, Dept Anat, Med Ctr, Kuala Lumpur 56000, Malaysia
关键词
immunohistochemistry; breast cancer; estrogen receptor; progesterone receptor; HER2; keratins; BASAL-LIKE SUBTYPE; MOLECULAR SUBTYPES; IN-SITU; EXPRESSION; CARCINOMAS; PHENOTYPE; BRCA1; CLASSIFICATION; CYTOKERATIN-5; MUTATIONS;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Breast cancer may be classified into luminal A, luminal B, HER2+/ER-, basal-like and normal-like subtypes based on gene expression profiling or immunohistochemical (IHC) characteristics. The main aim of the present study was to classify breast cancer into molecular subtypes based on immunohistochemistry findings and correlate the subtypes with clinicopathological factors. Two hundred and seventeen primary breast carcinomas tumor tissues were immunostained for ER, PR, HER2, CK5/6, EGFR, CK8/18, p53 and Ki67 using tissue microarray technique. All subtypes were significantly associated with Malay ethnic background (p=0.035) compared to other racial origins. The most common subtypes of breast cancers were luminal A and was significantly associated with low histological grade (p < 0.000) and p53 negativity (p=0.003) compared to HER2+/ER-, basal-like and normal-like subtypes with high histological grade (p < 0.000) and p53 positivity (p=0.003). Luminal B subtype had the smallest mean tumor size (p=0.009) and also the highest mean number of lymph nodes positive (p=0.032) compared to other subtypes. All markers except EGFR and Ki67 were significantly associated with the subtypes. The most common histological type was infiltrating ductal carcinoma, NOS. Majority of basal-like subtype showed comedo-type necrosis (68.8%) and infiltrative margin (81.3%). Our studies suggest that IHC can be used to identify the different subtypes of breast cancer and all subtypes were significantly associated with race, mean tumor size, mean number of lymph node positive, histological grade and all immunohistochemical markers except EGFR and Ki67.
引用
收藏
页码:669 / 677
页数:9
相关论文
共 41 条
  • [1] American Joint Committee on Cancer, 2010, AJCC CANC STAG HDB
  • [2] [Anonymous], 2003, WHO CLASSIFICATION T
  • [3] Basal-like breast carcinomas: clinical outcome and response to chemotherapy
    Banerjee, S.
    Reis-Filho, J. S.
    Ashley, S.
    Steele, D.
    Ashworth, A.
    Lakhani, S. R.
    Smith, I. E.
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2006, 59 (07) : 729 - 735
  • [4] Gene expression profiling identifies molecular subtypes of inflammatory breast cancer
    Bertucci, F
    Finetti, P
    Rougemont, J
    Charafe-Jauffret, E
    Cervera, N
    Tarpin, C
    Nguyen, C
    Xerri, L
    Houlgatte, M
    Jacquemier, J
    Viens, P
    Birnbaum, D
    [J]. CANCER RESEARCH, 2005, 65 (06) : 2170 - 2178
  • [5] Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages:: A new cell biological concept
    Böcker, W
    Moll, R
    Poremba, C
    Holland, R
    van Diest, PJ
    Dervan, P
    Bürger, H
    Wai, D
    Diallo, RI
    Brandt, B
    Herbst, H
    Schmidt, A
    Lerch, MM
    Buchwallow, IB
    [J]. LABORATORY INVESTIGATION, 2002, 82 (06) : 737 - 745
  • [6] The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes
    Carey, Lisa A.
    Dees, E. Claire
    Sawyer, Lynda
    Gatti, Lisa
    Moore, Dominic T.
    Collichio, Frances
    Ollila, David W.
    Sartor, Carolyn I.
    Graham, Mark L.
    Perou, Charles M.
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (08) : 2329 - 2334
  • [7] Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
    Carey, Lisa A.
    Perou, Charles M.
    Livasy, Chad A.
    Dressler, Lynn G.
    Cowan, David
    Conway, Kathleen
    Karaca, Gamze
    Troester, Melissa A.
    Tse, Chiu Kit
    Edmiston, Sharon
    Deming, Sandra L.
    Geradts, Joseph
    Cheang, Maggie C. U.
    Nielsen, Torsten O.
    Moorman, Patricia G.
    Earp, H. Shelton
    Millikan, Robert C.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21): : 2492 - 2502
  • [8] Basal-like breast cancer defined by five biomarkers has superior prognostic value then triple-negative phenotype
    Cheang, Maggie C. U.
    Voduc, David
    Bajdik, Chris
    Leung, Samuel
    McKinney, Steven
    Chia, Stephen K.
    Perou, Charles M.
    Nielsen, Torsten O.
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (05) : 1368 - 1376
  • [9] Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
    Cheang, Maggie C. U.
    Chia, Stephen K.
    Voduc, David
    Gao, Dongxia
    Leung, Samuel
    Snider, Jacqueline
    Watson, Mark
    Davies, Sherri
    Bernard, Philip S.
    Parker, Joel S.
    Perou, Charles M.
    Ellis, Matthew J.
    Nielsen, Torsten O.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (10): : 736 - 750
  • [10] Protein expression profiling in high-risk breast cancer patients treated with high-dose or conventional dose-dense chemotherapy
    Diallo-Danebrock, Raihanatou
    Ting, Evelyn
    Gluz, Oleg
    Herr, Alexander
    Mohrmann, Svjetlana
    Geddert, Helene
    Rody, Achim
    Schaefer, Karl-Ludwig
    Baldus, Stephan E.
    Hartmann, Arndt
    Wild, Peter J.
    Burson, Michael
    Gabbert, Helmut E.
    Nitz, Ulrike
    Poremba, Christopher
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (02) : 488 - 497